GYRE (STOCKS)
Gyre Therapeutics, Inc. Common Stock
$7.600000
+0.210000 (+2.84%)
Prev close: $7.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ping Zhang
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $703.12M
- Employees
- 574
- P/E (TTM)
- 328.44
- P/B (TTM)
- 6.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $116.59M |
| Benefits Costs and Expenses | $102.15M |
| Cost Of Revenue | $5.42M |
| Costs And Expenses | $105.10M |
| Gross Profit | $111.17M |
| Operating Expenses | $105.10M |
| Research and Development | $13.70M |
| Other Operating Expenses | $91.40M |
| Operating Income/Loss | $11.49M |
| Income/Loss From Continuing Operations After Tax | $9.88M |
| Income/Loss From Continuing Operations Before Tax | $14.44M |
| Income Tax Expense/Benefit | $4.56M |
| Income Tax Expense/Benefit, Current | $5.66M |
| Income Tax Expense/Benefit, Deferred | -$1.11M |
| Interest Income/Expense After Provision For Losses | $1.75M |
| Interest Income/Expense Operating, Net | $1.75M |
| Net Income/Loss | $9.88M |
| Net Income/Loss Attributable To Noncontrolling Interest | $4.85M |
| Net Income/Loss Attributable To Parent | $9.88M |
| Net Income/Loss Available To Common Stockholders, Basic | $5.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $4.85M |
| Preferred Stock Dividends And Other Adjustments | $4.85M |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $0.06 |
| Diluted Earnings Per Share | $0.02 |
| Basic Average Shares | 89,344,622 |
| Diluted Average Shares | 103,180,037 |
| Assets | $166.13M |
| Current Assets | $102.37M |
| Noncurrent Assets | $63.76M |
| Fixed Assets | $23.60M |
| Other Non-current Assets | $40.16M |
| Liabilities | $23.85M |
| Current Liabilities | $18.29M |
| Accounts Payable | $124.00K |
| Other Current Liabilities | $18.16M |
| Noncurrent Liabilities | $5.56M |
| Equity | $142.28M |
| Equity Attributable To Noncontrolling Interest | $36.25M |
| Equity Attributable To Parent | $106.03M |
| Liabilities And Equity | $166.13M |
| Net Cash Flow From Operating Activities | $1.01M |
| Net Cash Flow From Operating Activities, Continuing | $1.01M |
| Net Cash Flow From Investing Activities | -$474.00K |
| Net Cash Flow From Investing Activities, Continuing | -$474.00K |
| Net Cash Flow From Financing Activities | $24.38M |
| Net Cash Flow From Financing Activities, Continuing | $24.38M |
| Net Cash Flow | $24.91M |
| Net Cash Flow, Continuing | $24.91M |
| Comprehensive Income/Loss | $12.52M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $5.67M |
| Comprehensive Income/Loss Attributable To Parent | $6.85M |
| Other Comprehensive Income/Loss | $2.64M |